Anke Unger
Impact in
- Clinical Biochemistry top 10%
- Advanced Glycation End Products research
Papers in
-
- Histone Deacetylase Inhibitors Research 3
- Melanoma and MAPK Pathways 3
- Cancer therapeutics and mechanisms 2
- Oncology 8
- Cytokine Signaling Pathways and Interactions 4
- Co-authors
- Markus O. Lederer (1 shared paper)C. Breitling‐Utzmann (1 shared paper)Stefan Laufer (4 shared papers)Bert Klebl (11 shared papers)Wolfgang Albrecht (3 shared papers)Matthias Baumann (5 shared papers)Jan Eickhoff (7 shared papers)Alexander Wolf (3 shared papers)
- Journals
- Journal of Medicinal Chemistry (7 papers)European Journal of Medicinal Chemistry (2 papers)Oncotarget (2 papers)Drug Metabolism and Disposition (1 paper)Pharmaceuticals (1 paper)
- Partner nations
- GermanyNorwayUnited Kingdom
In The Last Decade
Anke Unger
22 papers receiving 404 citations
Peers
Comparison fields: 5 of 72
- Clinical Biochemistry 42
- Sensory Systems 21
- Virology 16
- Microbiology 21
- Organic Chemistry 97
Countries citing papers authored by Anke Unger
This map shows the geographic impact of Anke Unger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anke Unger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anke Unger more than expected).
Fields of papers citing papers by Anke Unger
This network shows the impact of papers produced by Anke Unger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anke Unger. The network helps show where Anke Unger may publish in the future.
Co-authors
The 25 scholars most cited alongside Anke Unger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 93 | |
| 2 | 2001 | 60 | |
| 3 | 2018 | 36 | |
| 4 | 2018 | 26 | |
| 5 | 2017 | 25 | |
| 6 | 2009 | 24 | |
| 7 | 2015 | 22 | |
| 8 | 2017 | 17 | |
| 9 | 2018 | 15 | |
| 10 | 2013 | 14 | |
| 11 | 2020 | 12 | |
| 12 | 2023 | 12 | |
| 13 | 2008 | 11 | |
| 14 | 2021 | 10 | |
| 15 | 2023 | 9 | |
| 16 | 2023 | 5 | |
| 17 | 2018 | 5 | |
| 18 | 2023 | 4 | |
| 19 | 2023 | 3 | |
| 20 | 2023 | 1 |
About Anke Unger
Anke Unger is a scholar working on Molecular Biology, Oncology, Immunology, Pharmacology and Organic Chemistry, having authored 26 papers that have together received 407 indexed citations. Recurring topics across this work include Immune cells in cancer (5 papers), Cytokine Signaling Pathways and Interactions (4 papers), Inflammatory mediators and NSAID effects (3 papers), Histone Deacetylase Inhibitors Research (3 papers), Melanoma and MAPK Pathways (3 papers), Quinazolinone synthesis and applications (2 papers), Cancer therapeutics and mechanisms (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Clinical Biochemistry (42 citations), Sensory Systems (21 citations), Virology (16 citations), Microbiology (21 citations) and Organic Chemistry (97 citations). Anke Unger has collaborated with scholars based in Germany, Norway and United Kingdom. Frequent co-authors include Markus O. Lederer, C. Breitling‐Utzmann, Stefan Laufer, Bert Klebl, Wolfgang Albrecht, Matthias Baumann, Jan Eickhoff, Alexander Wolf, Gunther Zischinsky and Isabel Zeitträger. Their work appears in journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, Oncotarget, Drug Metabolism and Disposition and Pharmaceuticals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.